A team of researchers has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings may help improve future ways to deliver ...

After spending years tracing the origin and migration pattern of an unusual type of immune cell in mice, researchers have ...

UbiVac’s DPV-001 induces Development of 1st in-patient generated TCR to Non-Small Cell Lung Cancer’s “Dark Matter” – Targets cancer without apparent toxicity UbiVac is thrilled to announce the first ...

FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

According to Rudolf Steiner and other scientists, 7-year cycles are extremely important to doctors, teachers, social ...

Without CD4 T helper cells, the immune system cannot recognize and coordinate a defensive response to diseases like HIV. This is when a person is said to be immunocompromised. During maturation, ...

A prior analysis of human antibody repertoires demonstrated that T cell epitopes decreased with increasing antibody maturation. However, that study didn't separate regulatory from effector T cell ...

The study, "Regulatory T Cell Epitope Content in Human Antibodies Decreases During Maturation", was conducted by Andres Gutierrez, PhD and Annie De Groot, MD of EpiVax, using existing antibody ...

A prior analysis of human antibody repertoires demonstrated that T cell epitopes decreased with increasing antibody maturation. However, that study didn't separate regulatory from effector T cell ...

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

Veteran turkey hunters know only too well that hunting spring gobblers on public land is difficult. Failing to score for days on end gets inside your ...